+1 347 708 0418
The Lung Cancer Diagnostic Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Lung Cancer Diagnostic Tests size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Lung Cancer Diagnostic Tests market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Lung Cancer Diagnostic Tests market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Market segment by Application, can be divided into
Precision Medicine
Personalized Medicine
Cancer Monitoring
Market segment by players, this report covers
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Lung Cancer Diagnostic Tests product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Lung Cancer Diagnostic Tests, with revenue, gross margin and global market share of Lung Cancer Diagnostic Tests from 2019 to 2021.
Chapter 3, the Lung Cancer Diagnostic Tests competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Lung Cancer Diagnostic Tests market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Lung Cancer Diagnostic Tests research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
1.2 Classification of Lung Cancer Diagnostic Tests by Type
1.2.1 Overview: Global Lung Cancer Diagnostic Tests Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Type in 2020
1.2.3 Immunoassays
1.2.4 Flow Cytometry
1.2.5 Rapid Tests
1.2.6 Molecular Assays
1.2.7 Tissue Arrays
1.2.8 Circulating Tumor Cells
1.2.9 Pharmacodiagnostics
1.2.10 Biomarkers
1.2.11 Other Diagnostics Methods
1.3 Global Lung Cancer Diagnostic Tests Market by Application
1.3.1 Overview: Global Lung Cancer Diagnostic Tests Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Precision Medicine
1.3.3 Personalized Medicine
1.3.4 Cancer Monitoring
1.4 Global Lung Cancer Diagnostic Tests Market Size & Forecast
1.5 Global Lung Cancer Diagnostic Tests Market Size and Forecast by Region
1.5.1 Global Lung Cancer Diagnostic Tests Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Lung Cancer Diagnostic Tests Market Size by Region, (2016-2021)
1.5.3 North America Lung Cancer Diagnostic Tests Market Size and Prospect (2016-2026)
1.5.4 Europe Lung Cancer Diagnostic Tests Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Lung Cancer Diagnostic Tests Market Size and Prospect (2016-2026)
1.5.6 South America Lung Cancer Diagnostic Tests Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Lung Cancer Diagnostic Tests Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Lung Cancer Diagnostic Tests Market Drivers
1.6.2 Lung Cancer Diagnostic Tests Market Restraints
1.6.3 Lung Cancer Diagnostic Tests Trends Analysis
2 Company Profiles
2.1 Advpharma Inc
2.1.1 Advpharma Inc Details
2.1.2 Advpharma Inc Major Business
2.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Product and Solutions
2.1.4 Advpharma Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Advpharma Inc Recent Developments and Future Plans
2.2 AIT Austrian Institute of Technology GmbH
2.2.1 AIT Austrian Institute of Technology GmbH Details
2.2.2 AIT Austrian Institute of Technology GmbH Major Business
2.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product and Solutions
2.2.4 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AIT Austrian Institute of Technology GmbH Recent Developments and Future Plans
2.3 Courtagen Life Sciences Inc
2.3.1 Courtagen Life Sciences Inc Details
2.3.2 Courtagen Life Sciences Inc Major Business
2.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product and Solutions
2.3.4 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Courtagen Life Sciences Inc Recent Developments and Future Plans
2.4 DiagnoCure Inc. (Inactive)
2.4.1 DiagnoCure Inc. (Inactive) Details
2.4.2 DiagnoCure Inc. (Inactive) Major Business
2.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product and Solutions
2.4.4 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 DiagnoCure Inc. (Inactive) Recent Developments and Future Plans
2.5 BioMark Diagnostics Inc.
2.5.1 BioMark Diagnostics Inc. Details
2.5.2 BioMark Diagnostics Inc. Major Business
2.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product and Solutions
2.5.4 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 BioMark Diagnostics Inc. Recent Developments and Future Plans
2.6 BioMarker Strategies LLC
2.6.1 BioMarker Strategies LLC Details
2.6.2 BioMarker Strategies LLC Major Business
2.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product and Solutions
2.6.4 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 BioMarker Strategies LLC Recent Developments and Future Plans
2.7 Emory University
2.7.1 Emory University Details
2.7.2 Emory University Major Business
2.7.3 Emory University Lung Cancer Diagnostic Tests Product and Solutions
2.7.4 Emory University Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Emory University Recent Developments and Future Plans
2.8 Epigenomics AG
2.8.1 Epigenomics AG Details
2.8.2 Epigenomics AG Major Business
2.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Product and Solutions
2.8.4 Epigenomics AG Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Epigenomics AG Recent Developments and Future Plans
2.9 GlycoZym
2.9.1 GlycoZym Details
2.9.2 GlycoZym Major Business
2.9.3 GlycoZym Lung Cancer Diagnostic Tests Product and Solutions
2.9.4 GlycoZym Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 GlycoZym Recent Developments and Future Plans
2.10 HalioDx SAS
2.10.1 HalioDx SAS Details
2.10.2 HalioDx SAS Major Business
2.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Product and Solutions
2.10.4 HalioDx SAS Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 HalioDx SAS Recent Developments and Future Plans
2.11 Louisville Bioscience, Inc.
2.11.1 Louisville Bioscience, Inc. Details
2.11.2 Louisville Bioscience, Inc. Major Business
2.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product and Solutions
2.11.4 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Louisville Bioscience, Inc. Recent Developments and Future Plans
2.12 Mayo Clinic US
2.12.1 Mayo Clinic US Details
2.12.2 Mayo Clinic US Major Business
2.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Product and Solutions
2.12.4 Mayo Clinic US Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Mayo Clinic US Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Lung Cancer Diagnostic Tests Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Lung Cancer Diagnostic Tests Players Market Share
3.2.2 Top 10 Lung Cancer Diagnostic Tests Players Market Share
3.2.3 Market Competition Trend
3.3 Lung Cancer Diagnostic Tests Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Lung Cancer Diagnostic Tests Revenue and Market Share by Type (2016-2021)
4.2 Global Lung Cancer Diagnostic Tests Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2016-2021)
5.2 Lung Cancer Diagnostic Tests Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Lung Cancer Diagnostic Tests Revenue by Type (2016-2026)
6.2 North America Lung Cancer Diagnostic Tests Revenue by Application (2016-2026)
6.3 North America Lung Cancer Diagnostic Tests Market Size by Country
6.3.1 North America Lung Cancer Diagnostic Tests Revenue by Country (2016-2026)
6.3.2 United States Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
6.3.3 Canada Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
6.3.4 Mexico Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Lung Cancer Diagnostic Tests Revenue by Type (2016-2026)
7.2 Europe Lung Cancer Diagnostic Tests Revenue by Application (2016-2026)
7.3 Europe Lung Cancer Diagnostic Tests Market Size by Country
7.3.1 Europe Lung Cancer Diagnostic Tests Revenue by Country (2016-2026)
7.3.2 Germany Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
7.3.3 France Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
7.3.5 Russia Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
7.3.6 Italy Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Type (2016-2026)
8.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Application (2016-2026)
8.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Region (2016-2026)
8.3.2 China Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
8.3.3 Japan Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
8.3.4 South Korea Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
8.3.5 India Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
8.3.7 Australia Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Lung Cancer Diagnostic Tests Revenue by Type (2016-2026)
9.2 South America Lung Cancer Diagnostic Tests Revenue by Application (2016-2026)
9.3 South America Lung Cancer Diagnostic Tests Market Size by Country
9.3.1 South America Lung Cancer Diagnostic Tests Revenue by Country (2016-2026)
9.3.2 Brazil Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
9.3.3 Argentina Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Type (2016-2026)
10.2 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Application (2016-2026)
10.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Country (2016-2026)
10.3.2 Turkey Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
10.3.4 UAE Lung Cancer Diagnostic Tests Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Lung Cancer Diagnostic Tests Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Lung Cancer Diagnostic Tests Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Lung Cancer Diagnostic Tests Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Lung Cancer Diagnostic Tests Revenue (USD Million) by Region (2016-2021)
Table 5. Global Lung Cancer Diagnostic Tests Revenue Market Share by Region (2021-2026)
Table 6. Advpharma Inc Corporate Information, Head Office, and Major Competitors
Table 7. Advpharma Inc Major Business
Table 8. Advpharma Inc Lung Cancer Diagnostic Tests Product and Solutions
Table 9. Advpharma Inc Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AIT Austrian Institute of Technology GmbH Corporate Information, Head Office, and Major Competitors
Table 11. AIT Austrian Institute of Technology GmbH Major Business
Table 12. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product and Solutions
Table 13. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Courtagen Life Sciences Inc Corporate Information, Head Office, and Major Competitors
Table 15. Courtagen Life Sciences Inc Major Business
Table 16. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product and Solutions
Table 17. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. DiagnoCure Inc. (Inactive) Corporate Information, Head Office, and Major Competitors
Table 19. DiagnoCure Inc. (Inactive) Major Business
Table 20. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product and Solutions
Table 21. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. BioMark Diagnostics Inc. Corporate Information, Head Office, and Major Competitors
Table 23. BioMark Diagnostics Inc. Major Business
Table 24. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product and Solutions
Table 25. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. BioMarker Strategies LLC Corporate Information, Head Office, and Major Competitors
Table 27. BioMarker Strategies LLC Major Business
Table 28. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product and Solutions
Table 29. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Emory University Corporate Information, Head Office, and Major Competitors
Table 31. Emory University Major Business
Table 32. Emory University Lung Cancer Diagnostic Tests Product and Solutions
Table 33. Emory University Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Epigenomics AG Corporate Information, Head Office, and Major Competitors
Table 35. Epigenomics AG Major Business
Table 36. Epigenomics AG Lung Cancer Diagnostic Tests Product and Solutions
Table 37. Epigenomics AG Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. GlycoZym Corporate Information, Head Office, and Major Competitors
Table 39. GlycoZym Major Business
Table 40. GlycoZym Lung Cancer Diagnostic Tests Product and Solutions
Table 41. GlycoZym Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. HalioDx SAS Corporate Information, Head Office, and Major Competitors
Table 43. HalioDx SAS Major Business
Table 44. HalioDx SAS Lung Cancer Diagnostic Tests Product and Solutions
Table 45. HalioDx SAS Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Louisville Bioscience, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Louisville Bioscience, Inc. Major Business
Table 48. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product and Solutions
Table 49. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Mayo Clinic US Corporate Information, Head Office, and Major Competitors
Table 51. Mayo Clinic US Major Business
Table 52. Mayo Clinic US Lung Cancer Diagnostic Tests Product and Solutions
Table 53. Mayo Clinic US Lung Cancer Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Lung Cancer Diagnostic Tests Revenue (USD Million) by Players (2019-2021)
Table 55. Global Lung Cancer Diagnostic Tests Revenue Share by Players (2019-2021)
Table 56. Breakdown of Lung Cancer Diagnostic Tests by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Lung Cancer Diagnostic Tests Players Head Office, Products and Services Provided
Table 58. Lung Cancer Diagnostic Tests Mergers & Acquisitions in the Past Five Years
Table 59. Lung Cancer Diagnostic Tests New Entrants and Expansion Plans
Table 60. Global Lung Cancer Diagnostic Tests Revenue (USD Million) by Type (2016-2021)
Table 61. Global Lung Cancer Diagnostic Tests Revenue Share by Type (2016-2021)
Table 62. Global Lung Cancer Diagnostic Tests Revenue Forecast by Type (2021-2026)
Table 63. Global Lung Cancer Diagnostic Tests Revenue by Application (2016-2021)
Table 64. Global Lung Cancer Diagnostic Tests Revenue Forecast by Application (2021-2026)
Table 65. North America Lung Cancer Diagnostic Tests Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Lung Cancer Diagnostic Tests Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Lung Cancer Diagnostic Tests Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Lung Cancer Diagnostic Tests Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Lung Cancer Diagnostic Tests Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Lung Cancer Diagnostic Tests Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Lung Cancer Diagnostic Tests Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Lung Cancer Diagnostic Tests Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Lung Cancer Diagnostic Tests Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Lung Cancer Diagnostic Tests Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Lung Cancer Diagnostic Tests Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Lung Cancer Diagnostic Tests Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Lung Cancer Diagnostic Tests Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Lung Cancer Diagnostic Tests Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Lung Cancer Diagnostic Tests Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Lung Cancer Diagnostic Tests Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Lung Cancer Diagnostic Tests Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Lung Cancer Diagnostic Tests Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Lung Cancer Diagnostic Tests Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Lung Cancer Diagnostic Tests Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Lung Cancer Diagnostic Tests Picture
Figure 2. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type in 2020
Figure 3. Immunoassays
Figure 4. Flow Cytometry
Figure 5. Rapid Tests
Figure 6. Molecular Assays
Figure 7. Tissue Arrays
Figure 8. Circulating Tumor Cells
Figure 9. Pharmacodiagnostics
Figure 10. Biomarkers
Figure 11. Other Diagnostics Methods
Figure 12. Lung Cancer Diagnostic Tests Revenue Market Share by Application in 2020
Figure 13. Precision Medicine Picture
Figure 14. Personalized Medicine Picture
Figure 15. Cancer Monitoring Picture
Figure 16. Global Lung Cancer Diagnostic Tests Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Lung Cancer Diagnostic Tests Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Lung Cancer Diagnostic Tests Revenue Market Share by Region (2016-2026)
Figure 19. Global Lung Cancer Diagnostic Tests Revenue Market Share by Region in 2020
Figure 20. North America Lung Cancer Diagnostic Tests Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Lung Cancer Diagnostic Tests Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Lung Cancer Diagnostic Tests Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Lung Cancer Diagnostic Tests Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Lung Cancer Diagnostic Tests Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Lung Cancer Diagnostic Tests Market Drivers
Figure 26. Lung Cancer Diagnostic Tests Market Restraints
Figure 27. Lung Cancer Diagnostic Tests Market Trends
Figure 28. Advpharma Inc Recent Developments and Future Plans
Figure 29. AIT Austrian Institute of Technology GmbH Recent Developments and Future Plans
Figure 30. Courtagen Life Sciences Inc Recent Developments and Future Plans
Figure 31. DiagnoCure Inc. (Inactive) Recent Developments and Future Plans
Figure 32. BioMark Diagnostics Inc. Recent Developments and Future Plans
Figure 33. BioMarker Strategies LLC Recent Developments and Future Plans
Figure 34. Emory University Recent Developments and Future Plans
Figure 35. Epigenomics AG Recent Developments and Future Plans
Figure 36. GlycoZym Recent Developments and Future Plans
Figure 37. HalioDx SAS Recent Developments and Future Plans
Figure 38. Louisville Bioscience, Inc. Recent Developments and Future Plans
Figure 39. Mayo Clinic US Recent Developments and Future Plans
Figure 40. Global Lung Cancer Diagnostic Tests Revenue Share by Players in 2020
Figure 41. Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 42. Global Top 3 Players Lung Cancer Diagnostic Tests Revenue Market Share in 2020
Figure 43. Global Top 10 Players Lung Cancer Diagnostic Tests Revenue Market Share in 2020
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 45. Global Lung Cancer Diagnostic Tests Revenue Share by Type in 2020
Figure 46. Global Lung Cancer Diagnostic Tests Market Share Forecast by Type (2021-2026)
Figure 47. Global Lung Cancer Diagnostic Tests Revenue Share by Application in 2020
Figure 48. Global Lung Cancer Diagnostic Tests Market Share Forecast by Application (2021-2026)
Figure 49. North America Lung Cancer Diagnostic Tests Sales Market Share by Type (2016-2026)
Figure 50. North America Lung Cancer Diagnostic Tests Sales Market Share by Application (2016-2026)
Figure 51. North America Lung Cancer Diagnostic Tests Revenue Market Share by Country (2016-2026)
Figure 52. United States Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Canada Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Mexico Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Europe Lung Cancer Diagnostic Tests Sales Market Share by Type (2016-2026)
Figure 56. Europe Lung Cancer Diagnostic Tests Sales Market Share by Application (2016-2026)
Figure 57. Europe Lung Cancer Diagnostic Tests Revenue Market Share by Country (2016-2026)
Figure 58. Germany Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. France Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. United Kingdom Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Russia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Italy Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Asia-Pacific Lung Cancer Diagnostic Tests Sales Market Share by Type (2016-2026)
Figure 64. Asia-Pacific Lung Cancer Diagnostic Tests Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Lung Cancer Diagnostic Tests Revenue Market Share by Region (2016-2026)
Figure 66. China Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Japan Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South Korea Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. India Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Southeast Asia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Australia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South America Lung Cancer Diagnostic Tests Sales Market Share by Type (2016-2026)
Figure 73. South America Lung Cancer Diagnostic Tests Sales Market Share by Application (2016-2026)
Figure 74. South America Lung Cancer Diagnostic Tests Revenue Market Share by Country (2016-2026)
Figure 75. Brazil Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Argentina Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Middle East and Africa Lung Cancer Diagnostic Tests Sales Market Share by Type (2016-2026)
Figure 78. Middle East and Africa Lung Cancer Diagnostic Tests Sales Market Share by Application (2016-2026)
Figure 79. Middle East and Africa Lung Cancer Diagnostic Tests Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. UAE Lung Cancer Diagnostic Tests Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
Buy
